Comparison of polyfluoroalkyl compound concentrations in maternal serum and amniotic fluid: A pilot study

Reproductive Toxicology

Volumn 34, Issue 3, 2012, Pages 312-316

  Stein, Cheryl R ^a   Wolff, Mary S ^a   Calafat, Antonia M ^b   Kato, Kayoko ^b   Engel, Stephanie M ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^c IL   (United States)

Author keywords

Amniotic fluid; Fluorocarbons; Maternal serum; Perfluorooctane sulfonate; Perfluorooctanoate; Pregnancy

Indexed keywords

PERFLUOROHEXANESULFONIC ACID; PERFLUORONONANOIC ACID; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; POLYFLUOROALKYL DERIVATIVE; POLYMER; UNCLASSIFIED DRUG;

ADULT; AMNIOCENTESIS; AMNION FLUID; ARTICLE; BIOLOGICAL MONITORING; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN EXPERIMENT; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MATERNAL SERUM; PATIENT MONITORING; PILOT STUDY; PREGNANCY; PROBABILITY; PROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; URINALYSIS;

ADULT; AMNIOTIC FLUID; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; FEMALE; FLUOROCARBONS; HUMANS; MATERNAL EXPOSURE; PILOT PROJECTS; PREGNANCY; SULFONIC ACIDS;

EID: 84865539904     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2012.05.039     Document Type: Article

References (38)

1. Perfluorooctanoic Acid (PFOA). Washington, DC: U.S. Environmental Protection Agency; 2009.
2. Perfluorooctanoic Acid (PFOA) and Fluorinated Telomers. Washington, DC: U.S. Environmental Protection Agency; 2009.
3. D'Eon J.C., Mabury S.A. Is indirect exposure a significant contributor to the burden of perfluorinated acids observed in humans?. Environmental Science and Technology 2011, 45:7974-7984.
4. Houde M., Martin J.W., Letcher R.J., Solomon K.R., Muir D.C. Biological monitoring of polyfluoroalkyl substances: a review. Environmental Science and Technology 2006, 40:3463-3473.
5. Calafat A.M., Kuklenyik Z., Reidy J.A., Caudill S.P., Tully J.S., Needham L.L. Serum concentrations of 11 polyfluoroalkyl compounds in the U.S. population: data from the national health and nutrition examination survey (NHANES). Environmental Science and Technology 2007, 41:2237-2242.
6. Calafat A.M., Wong L.Y., Kuklenyik Z., Reidy J.A., Needham L.L. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environmental Health Perspectives 2007, 115:1596-1602.
7. Kato K., Wong L.Y., Jia L.T., Kuklenyik Z., Calafat A.M. Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008 (dagger). Environmental Science and Technology 2011.
8. Bartell S.M., Calafat A.M., Lyu C., Kato K., Ryan P.B., Steenland K. Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environmental Health Perspectives 2010, 118:222-228.
9. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Butenhoff J.L., et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environmental Health Perspectives 2007, 115:1298-1305.
10. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicological Sciences 2007, 99:366-394.
11. Lau C., Butenhoff J.L., Rogers J.M. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicology and Applied Pharmacology 2004, 198:231-241.
12. Olsen G.W., Butenhoff J.L., Zobel L.R. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reproductive Toxicology 2009, 27:212-230.
13. Luebker D.J., Case M.T., York R.G., Moore J.A., Hansen K.J., Butenhoff J.L. Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology 2005, 215:126-148.
14. Fuentes S., Colomina M.T., Vicens P., Domingo J.L. Influence of maternal restraint stress on the long-lasting effects induced by prenatal exposure to perfluorooctane sulfonate (PFOS) in mice. Toxicology Letters 2007, 171:162-170.
15. Butenhoff J.L., Kennedy G.L., Frame S.R., O'Connor J.C., York R.G. The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. Toxicology 2004, 196:95-116.
16. Apelberg B.J., Witter F.R., Herbstman J.B., Calafat A.M., Halden R.U., Needham L.L., et al. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environmental Health Perspectives 2007, 115:1670-1676.
17. Fei C., McLaughlin J.K., Tarone R.E., Olsen J. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environmental Health Perspectives 2007, 115:1677-1682.
18. Fei C., McLaughlin J.K., Tarone R.E., Olsen J. Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort. American Journal of Epidemiology 2008, 168:66-72.
19. Washino N., Saijo Y., Sasaki S., Kato S., Ban S., Konishi K., et al. Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environmental Health Perspectives 2009, 117:660-667.
20. Nolan L.A., Nolan J.M., Shofer F.S., Rodway N.V., Emmett E.A. The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reproductive Toxicology 2009, 27:231-238.
21. Stein C.R., Savitz D.A., Dougan M. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. American Journal of Epidemiology 2009, 170:837-846.
22. Savitz D.A., Stein C.R., Bartell S.M., Elston B., Gong J., Shin H.M., et al. Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community. Epidemiology 2012, 23:386-392.
23. Fenton S.E., Reiner J.L., Nakayama S.F., Delinsky A.D., Stanko J.P., Hines E.P., et al. Analysis of PFOA in dosed CD-1 mice. Part 2. Disposition of PFOA in tissues and fluids from pregnant and lactating mice and their pups. Reproductive Toxicology 2009, 27:365-372.
24. Loccisano A.E., Campbell J.L., Butenhoff J.L., Andersen M.E., Clewell H.J. Evaluation of placental and lactational pharmacokinetics of PFOA and PFOS in the pregnant, lactating, fetal and neonatal rat using a physiologically based pharmacokinetic model. Reproductive Toxicology 2011.
25. Fromme H., Mosch C., Morovitz M., Alba-Alejandre I., Boehmer S., Kiranoglu M., et al. Pre- and postnatal exposure to perfluorinated compounds (PFCs). Environmental Science and Technology 2010, 44:7123-7129.
26. Kim S.K., Lee K.T., Kang C.S., Tao L., Kannan K., Kim K.R., et al. Distribution of perfluorochemicals between sera and milk from the same mothers and implications for prenatal and postnatal exposures. Environmental Pollution 2011, 159:169-174.
27. Liu J., Li J., Liu Y., Chan H.M., Zhao Y., Cai Z., et al. Comparison on gestation and lactation exposure of perfluorinated compounds for newborns. Environment International 2011, 37:1206-1212.
28. Inoue K., Okada F., Ito R., Kato S., Sasaki S., Nakajima S., et al. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environmental Health Perspectives 2004, 112:1204-1207.
29. Midasch O., Drexler H., Hart N., Beckmann M.W., Angerer J. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. International Archives of Occupational and Environmental Health 2007, 80:643-648.
30. Monroy R., Morrison K., Teo K., Atkinson S., Kubwabo C., Stewart B., et al. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environmental Research 2008, 108:56-62.
31. Jensen M.S., Norgaard-Pedersen B., Toft G., Hougaard D.M., Bonde J.P., Cohen A., et al. Phthalates and perfluorooctanesulfonic acid in human amniotic fluid: temporal trends and timing of amniocentesis in pregnancy. Environmental Health Perspectives 2012.
32. Kuklenyik Z., Needham L.L., Calafat A.M. Measurement of 18 perfluorinated organic acids and amides in human serum using on-line solid-phase extraction. Analytical Chemistry 2005, 77:6085-6091.
33. Beesoon S., Webster G.M., Shoeib M., Harner T., Benskin J.P., Martin J.W. Isomer profiles of perfluorochemicals in matched maternal, cord, and house dust samples: manufacturing sources and transplacental transfer. Environmental Health Perspectives 2011, 119:1659-1664.
34. Moore K.L., Persaud T.V.N. The developing human: clinically oriented embryology 2003, Saunders, Philadelphia, PA. 7th ed.
35. Luo Z., Shi X., Hu Q., Zhao B., Huang M. Structural evidence of perfluorooctane sulfonate transport by human serum albumin. Chemical Research in Toxicology 2012.
36. Kleeberg J., Polishuk W.Z. Lipid determinations in maternal and foetal blood. Journal of Obstetrics and Gynaecology of the British Commonwealth 1963, 70:701-704.
37. Salvalaglio M., Muscionico I., Cavallotti C. Determination of energies and sites of binding of PFOA and PFOS to human serum albumin. Journal of Physical Chemistry B 2010, 114:14860-14874.
38. Harada K., Inoue K., Morikawa A., Yoshinaga T., Saito N., Koizumi A. Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. Environmental Research 2005, 99:253-261.